Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 3501 - 3525 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AW02
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260341 1699.913169 C78H141NO38
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type IV B antigen(d18:1/16:0)
44260244 1696.913503 C78H140N2O37
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BC01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261644 1696.913503 C78H140N2O37
Gangliosides LMSP0601AF01
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262004 1695.893102 C77H137N3O37
Gangliosides LMSP0601BD02
  • Fuc-GM1(d18:1/18:0)
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262197 1691.934572 C79H141N3O35
Gangliosides LMSP0601CH02
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • Sialyl-Lea(d18:1/18:0)
44262429 1691.934572 C79H141N3O35
Gangliosides LMSP0601DL02
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • sialyl-Lea(d18:1/18:0)
44262637 1691.934572 C79H141N3O35
Gangliosides LMSP0601DS02
  • Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262693 1691.934572 C79H141N3O35
Gangliosides LMSP0601EE02
  • NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • sialyl-Lex(d18:1/18:0)
44262781 1691.934572 C79H141N3O35
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ06
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260297 1691.012093 C82H150N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF06
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260417 1691.012093 C82H150N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA06
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261633 1691.012093 C82H150N2O33
Diacylglycerophosphoinositolglycans LMGP15010228
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:0/18:0)
126457596 1690.868208 C76H139O38P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ08
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260299 1688.996443 C82H148N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF08
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44260419 1688.996443 C82H148N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA08
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44261635 1688.996443 C82H148N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BB03
  • GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260382 1688.971291 C80H144N4O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AL03
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261902 1688.971291 C80H144N4O33
Diacylglycerophosphoinositolglycans LMGP15010229
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:0/18:1(9Z))
126457597 1688.852558 C76H137O38P
Diacylglycerophosphoinositolglycans LMGP15010234
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:1(9Z)/18:0)
126457602 1688.852558 C76H137O38P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BH05
  • Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260432 1688.012427 C82H149N3O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AG05
  • Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260536 1688.012427 C82H149N3O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AF05
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • type I A antigen(d18:1/24:0)
44260656 1688.012427 C82H149N3O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AK05
  • Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260696 1688.012427 C82H149N3O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AR05
  • GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260752 1688.012427 C82H149N3O32

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024